 | Theravance Biopharma Inc (NASDAQ:TBPH) Short Interest Update
www.americanbankingnews.com - September 12 at 8:26 PM |
| $14.96 Million in Sales Expected for Theravance Biopharma Inc (NASDAQ:TBPH) This Quarter
www.americanbankingnews.com - September 12 at 5:43 AM |
| Theravance Biopharma (NASDAQ:TBPH) Stock Rating Reaffirmed by Piper Jaffray Companies
www.americanbankingnews.com - September 11 at 9:51 PM |
 | Theravance Biopharma Breaks Above 200-Day Moving Average - Bullish for TBPH
www.nasdaq.com - September 11 at 2:43 PM |
| Theravance Biopharma Target of Unusually Large Options Trading (NASDAQ:TBPH)
www.americanbankingnews.com - September 11 at 8:39 AM |
| Theravance Biopharma Inc (NASDAQ:TBPH) Expected to Announce Earnings of -$1.04 Per Share
www.americanbankingnews.com - September 10 at 1:01 PM |
 | Theravance inhalable lung disease candidate shows encouraging action in early-stage study
seekingalpha.com - September 9 at 1:52 PM |
 | Theravance Biopharma Reports Positive Results from Phase 1 Clinical Trial of TD-8236, an Investigational, Lung-Selective, Inhaled Pan-Janus Kinase (JAK) Inhibitor for Inflammatory Lung Diseases
finance.yahoo.com - September 9 at 1:52 PM |
| Theravance Biopharma Inc (NASDAQ:TBPH) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - September 7 at 2:39 AM |
| Reviewing NuCana (NASDAQ:NCNA) & Theravance Biopharma (NASDAQ:TBPH)
www.americanbankingnews.com - September 6 at 2:54 PM |
| Theravance Biopharma: Gaining Traction
seekingalpha.com - August 21 at 7:39 PM |
| How Theravance Biopharma, Inc. (NASDAQ:TBPH) Can Impact Your Portfolio Volatility
finance.yahoo.com - August 11 at 10:33 AM |
| Esperion (ESPR) Q2 Loss Wider Than Expected, Revenues Beat
finance.yahoo.com - August 9 at 8:53 AM |
| Edited Transcript of TBPH earnings conference call or presentation 31-Jul-19 12:00pm GMT
finance.yahoo.com - August 1 at 6:36 PM |
| Theravance (TBPH) Q2 Loss Narrower, Revenues Beat Estimates
finance.yahoo.com - August 1 at 6:36 PM |
| Theravance Biopharma, Inc. (TBPH) Q2 2019 Earnings Call Transcript
finance.yahoo.com - July 31 at 5:44 PM |
| Theravance's ampreloxetine shows positive effect in mid-stage nOH study; shares up 2%
seekingalpha.com - July 22 at 6:03 PM |
| Theravance Biopharma Reports New Data from Phase 2 Study of Ampreloxetine (TD-9855) in Oral Presentation at 32nd European Neurology Congress
finance.yahoo.com - July 22 at 9:54 AM |
| How Much Did Theravance Biopharma, Inc.'s (NASDAQ:TBPH) CEO Pocket Last Year?
finance.yahoo.com - June 27 at 5:35 PM |
| After An Exaggerated Sell-Off, Theravance Should Recover Soon
seekingalpha.com - June 24 at 5:26 PM |
| Theravance Biopharma Reports New Data from Phase 2 Study of Ampreloxetine (TD-9855) in Presentation at 2019 International Association of Parkinsonism and Related Disorders (IAPRD) World Congress
finance.yahoo.com - June 18 at 5:48 PM |
| Introducing Theravance Biopharma (NASDAQ:TBPH), The Stock That Slid 54% In The Last Five Years
finance.yahoo.com - June 17 at 6:32 PM |
| Theravance Biopharma and Mylan Expand YUPELRI® (revefenacin) Development and Commercialization Agreement to Include China and Adjacent Territories
finance.yahoo.com - June 14 at 10:48 AM |
| Theravance Bio (TBPH) Down 27.7% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - June 6 at 5:49 PM |
| Theravance Bio's TD-1473 shows encouraging action in early-stage UC study
seekingalpha.com - May 21 at 11:36 AM |
| Oversold Conditions For Theravance Biopharma (TBPH)
www.nasdaq.com - May 20 at 12:35 PM |
 | Theravance Biopharma Inc. (TBPH) Q1 2019 Earnings Call Transcript
www.fool.com - May 15 at 12:13 AM |
 | Theravance Biopharma Announces Data from Phase 1b Study of TD-1473 to be Featured in Oral Presentation at Digestive Disease Week (DDW) 2019
www.prnewswire.com - May 14 at 9:50 AM |
| Theravance Biopharma (TBPH) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 8 at 9:30 AM |
| Edited Transcript of TBPH earnings conference call or presentation 7-May-19 9:00pm GMT
finance.yahoo.com - May 8 at 9:30 AM |
| Theravance Biopharma, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update
finance.yahoo.com - May 7 at 6:01 PM |
| Commit To Purchase Theravance Biopharma At $20, Earn 11.7% Annualized Using Options
www.nasdaq.com - May 2 at 6:35 PM |
| Here’s What Hedge Funds Think About Theravance Biopharma Inc (TBPH)
finance.yahoo.com - May 2 at 6:35 PM |
| Theravance Biopharma to Report First Quarter 2019 Financial Results on May 7
finance.yahoo.com - April 30 at 5:57 PM |
| Read This Before Buying Theravance Biopharma, Inc. (NASDAQ:TBPH) Shares
finance.yahoo.com - April 24 at 9:34 AM |
| Theravance Biopharma to Present at the 18th Annual Needham Healthcare Conference
finance.yahoo.com - April 2 at 11:09 AM |
| Why Is Theravance Bio (TBPH) Down 7.9% Since Last Earnings Report?
finance.yahoo.com - March 28 at 6:08 PM |
| Theravance Biopharma Announces Ampreloxetine (TD-9855) Phase 2 Study Results Selected for Oral Presentation at 32nd European Neurology Congress
finance.yahoo.com - March 25 at 9:09 AM |
| Theravance Biopharma Announces First Patient Dosed in Phase 2b/3 Study of TD-1473 in Patients with Ulcerative Colitis
finance.yahoo.com - March 12 at 10:47 AM |
 | Theravance Biopharma Inc.
www.barrons.com - March 11 at 10:57 AM |
| Edited Transcript of TBPH earnings conference call or presentation 26-Feb-19 10:00pm GMT
finance.yahoo.com - February 27 at 9:41 AM |
| Theravance Biopharma Inc (TBPH) Q4 2018 Earnings Conference Call Transcript
www.fool.com - February 26 at 11:32 PM |
| Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
finance.yahoo.com - February 26 at 5:43 PM |
| Theravance Biopharma, Inc. (TBPH)
finance.yahoo.com - February 26 at 10:00 AM |
| Frontier Communications' (FTR) Q4 Earnings: What's in Store?
finance.yahoo.com - February 21 at 10:09 AM |
| Theravance Biopharma to Present at the 8th Annual SVB Leerink Global Healthcare Conference
finance.yahoo.com - February 21 at 10:09 AM |
| Theravance Biopharma to Report Fourth Quarter and Full Year 2018 Financial Results on February 26
finance.yahoo.com - February 19 at 5:55 PM |
| What's in Store for Telefonica Brasil (VIV) in Q4 Earnings?
finance.yahoo.com - February 18 at 5:09 PM |
| Theravance Biopharma Announces First Patient Dosed in Registrational Phase 3 Study of Ampreloxetine (TD-9855) for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension
finance.yahoo.com - January 28 at 9:33 AM |
| With $500M in reserve, biotech cuts 49 jobs to focus on maturing drug pipeline
finance.yahoo.com - January 23 at 9:22 AM |
